Natriumthiosulfaat Hope (Sodium Thiosulfate)

Sodium Thiosulfate, the active ingredient in Natriumthiosulfaat Hope, is a chelating agent presented as an injectable solution for intravenous use. It is employed as an antidote for cyanide poisoning and as a treatment option in calciphylaxis and radiation‑induced mucositis.

GNH USA supplies Natriumthiosulfaat Hope as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Sodium Thiosulfate is used in clinical situations that require detoxification of cyanide or calcium chelation. - Cyanide poisoning: rapidly converts cyanide to the less toxic thiocyanate for renal excretion. - Calciphylaxis: chelates calcium deposits in small vessels, helping to reduce painful skin lesions. - Radiation‑induced mucositis: mitigates mucosal injury and promotes healing in patients receiving radiotherapy.

Sodium Thiosulfate may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Hypotension: transient drop in blood pressure during infusion. - Headache: occasional mild headache during or after administration.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Metabolic acidosis: significant acid‑base disturbance, especially in renal impairment. - Renal impairment: worsening kidney function in susceptible patients. - Hemolysis: breakdown of red blood cells, observed rarely. - Arrhythmia: irregular heart rhythm in high‑risk individuals.

When using Sodium Thiosulfate, clinicians should consider several safety measures. - Renal function: evaluate baseline kidney function and monitor during therapy. - Blood pressure: observe for hypotension, especially during rapid infusion. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Concomitant cyanide sources: avoid exposure to additional cyanide‑generating agents. - Calcium supplements: assess need, as they may diminish chelation efficacy. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Sodium Thiosulfate can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Nitroprusside: may increase cyanide production, worsening toxicity. - High‑dose vitamin B12: can interfere with thiosulfate metabolism. - Calcium supplements: may reduce the drug's calcium‑chelation effect.

Moderate Interactions (Monitor Closely): - Loop diuretics: may alter electrolyte balance, necessitating monitoring. - ACE inhibitors: can potentiate hypotensive effects during infusion. - Anticoagulants: may increase bleeding risk, requiring careful observation.